Eosinophil major basic protein (MBP) in relation to IgA antibodies to epidermal transglutaminase in dermatitis herpetiformis;Główne białko zasadowe eozynofilów (eosinophil major basic protein - MBP) a przeciwciała IgA przeciwko naskórkowej transglutaminazie w opryszczkowatym zapaleniu skóry

Dermatologia Klinicza

Volumn 7, Issue 2, 2005, Pages 67-71

  Wolnik Trzeciak, Grazyna ^a   Bowszyc Dmochowska, Monika ^a   Górna, Agnieszka ^b   Nieruchalska, Edyta ^b   Kaczmarek, Elzbieta ^b   Dmochowski, Marian ^a  

^a Katedra i Klinika Dermatologii   (Poland)

^b NONE   (Poland)

Author keywords

Dermatitis herpetiformis; Eosinophil; Epidermal transglutaminase; IgA; MBP

Indexed keywords

MAJOR BASIC PROTEIN; PEROXIDASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; STREPTAVIDIN;

ANTIBODY DETECTION; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATITIS HERPETIFORMIS; DERMOEPIDERMAL JUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUTROPHIL; PEMPHIGOID; THREE DIMENSIONAL IMAGING; WONOKAN;

EID: 20344386998     PISSN: 17307201     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Braun-Falco O., Plewig G., Wolff H.H., Burgdorf W.H.: Dermatology. Springer, Berlin, 2000, 687-689.
2. Wojnarowska F., Briggaman R.A.: Management of blistering diseases. Chapman and Hall Ltd, London, 1990, 139-160.
3. Marietta E., Black K., Camilleri M., Krause P., Rogers R.S. III, David C., Pittelkow M.R., Murray J.A.: A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest., 2004, 114, 1090-1097.
4. Caproni M., Cardinali C., D'Agata A., Selvaggi W.: Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-like cytokines in dermatitis herpetiformis. Int. Arch. Allerg. Immunol., 2002, 128, 67-72.
5. Kowalski M.L.: Immunologia kliniczna. Mediton, Łodź, 2000, 202-204.
6. Sárdy M., Kárpáti S., Merkl B., Paulsson M., Smyth N.: Epidermal transglutaminase (Tgase 3) is the autoantigen of dermatitis herpetiformis. J. Exp. Med., 2002, 195, 747-757.
7. Desreumaux P., Janin A., Delaporte E., Dubucquoi S., Piette F., Cartot A., Capron M., Colombel J.F.: Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of patient with dermatitis herpetiformis. Gut, 1995, 37, 132-135.
8. Bowszyc-Dmochowska M., Gibowski M., Dmochowski M.: Eozynofile, a nie neutrofile, sa̧ zazwyczaj najliczniejsze w pȩcherzach w ludzkim pemfigoidzie pȩcherzowym. Postȩpy Dermatol., 2000, 17, 321-325.
9. D'Auria L., Pietravalle M., Mastroianni A., Ferraro C., Mussi A., Bonifati C., Giacalone B., Ameglio F.: IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and di-sease severity. Arch. Dermatol. Res., 1998, 290, 25-27.
10. Wakugawa M., Nakamura K., Hino H., Toyama K., Hattori N., Okochi H., Yamada H., Hirai K., Tamaki K., Furues M.: Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br. J. Dermatol., 2000, 143, 112-116.
11. Shrikhande M., Hunziker T., Braathen L.R., Pichler W.J., Dahlnden C.A., Yawalkar N.: Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid. Acta Derm. Venereol., 2000, 80, 277-280.
12. Graeber M., Baker B.S., Garioch J.J., Valdimarsson H., Leonard J.N., Fry L.: The rote of cytokines in the generation of skin lesions in dermatitis herpetiformis. Br. J. Dermatol., 1993, 129, 530-532.
13. Monteiro R.C., van de Winkel G.J.: IgA Fc receptors. Ann. Rev. Immunol., 2003, 21, 177-204.
14. Dubucquoi S., Desreumaux P., Janin A., Klein O., Goldman M. Javernier J., Capron A., Capron M.: Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Mad., 1994, 179, 703-708.
15. Murata K., Sugie K., Takamure M., Fujimoto T., Ueno S.: Eosinophilic major basic protein and interleukin 5 in eosinophilic myositis. Eur. J. Neurol., 2003, 10, 35-38.
16. Kita H., Weiler D.A., Abu-Ghazaleh R., Sanderson C.J., Gleich G.J.: Release of granule proteins from eosinophils cultured with IL-5. J. Immunol., 1992, 149, 629-635.
17. Desreumax P., Delaporte E., Colombel J.F., Capron M., Cortot A., Janin A.: Similar IL-5, IL-3, and GM-CSF synthesis by eosinophils in the jejunal mucosa of patients with celiac disease and dermatitis herpetiformis. Clin. Immunol. Immunopathol., 1998, 88, 14-21.
18. Colombel J.F., Torpier G., Janin A., Klein O., Cortot A., Capron M.: Activated eosinophils in adult coeliac disease: evidence for local release of major basic protein. Gut, 1992, 33, 1190-1194.
19. Davis M.D.P., Plager D.A., George T.J., Weiss E.A., Gleich G.J., Leiferman K.M.: Interactions of eosinophil granule proteins with skin: limits of detection, persistance, and vasopermeabilization. J. Allergy Clin. Immunol., 2003, 112, 988-994.
20. Abu-Ghazaleh R.I., Fujisawa T., Mestecky J., Kyle R.A., Gleich G.J.: IgA-induced eosinophil degranulation. J. Immunol., 1989, 142, 2393-2400.